The Longevity Genes in Founder Populations Project
NCT00707694
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Extreme Longevity
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Albert Einstein College of Medicine
- Last updated on ClinicalTrials.gov
- January 2, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 2
- Private Homes · New York, NY
- Hebrew Home Riverdale · Riverdale, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.